BDX News & Events

Becton Dickinson and Envetec announced the successful completion of a joint feasibility study to test the ability to recycle polystyrene petri dishes into new, high-quality manufacturing feedstock. The results of the pilot study suggest that similar high-quality polymers, including polystyrene, polyester, polypropylene, and polyethylene, could be reused in the manufacturing supply chain after being safely disinfected and processed. These polymers find extensive use in medical devices.

The company announced it repurchased $250M in BD stock to date in FY26. In addition, the board has authorized the company to repurchase up to 10 million shares of BD common stock in addition to the shares that remain available under the board's previous authorizations in 2021 and 2025. The authorizations provide the company the ability to repurchase shares of its common stock through open market purchases, privately negotiated transactions or other methods.

BD (BDX) announced that the company's Board of Directors has set the close of business on February 5 as the record date for the previously announced spin-off of BD's Biosciences & Diagnostic Solutions business to BD's shareholders. Immediately following the spin-off, the spun-off entity will be combined with Waters Corporation (WAT) in a Reverse Morris Trust transaction. The combination is expected to be completed on February 9, subject to the satisfaction of customary closing conditions.